Batala Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Gujranwala · Pakistan
Gujranwala-based pharmaceutical manufacturer represented in current DRAP regulatory and product-quality records.
Batala Pharmaceuticals products in Pakistan
Batala Pharmaceuticals has 50 medicine presentations registered in Pakistan under 33 brands, covering 29 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Flint (Metronidazole), Lumerin DS (Artemether + Lumefantrine), Omeprazole (Omeprazole) and B-Dexy (Doxycycline). 50 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- 23/B, Small Industrial Estate No. 2, Gujranwala, Pakistan
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 50%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Batala Pharmaceuticals is priced against the market
49 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Albendazole | Albendazole | 200 mg | Tablet | 2's | 057492 | PKR 17.61 | PKR 8.81/tablet | 🔒 Pharma Pro |
| Allotal | Allopurinol | 300 mg | Tablet | 2x10's | 063356 | PKR 123.18 | PKR 6.16/tablet | 🔒 Pharma Pro |
| AML | Amlodipine | 5 mg | Tablet | 2 x 10's | 026726 | PKR 175.97 | PKR 8.80/tablet | 🔒 Pharma Pro |
| B Zole | Clotrimazole | 2% | Cream | 35gm | 073094 | PKR 105.59 | PKR 3.02/g | 🔒 Pharma Pro |
| B-Dexy | Doxycycline | 100 mg | Capsule | 5x10's | 077680 | PKR 351.93 | PKR 7.04/capsule | 🔒 Pharma Pro |
| B-Dexy | Doxycycline | 100 mg | Capsule | 10 x 10's | 077680 | PKR 689.80 | PKR 6.90/capsule | 🔒 Pharma Pro |
| B-Flucon | Clindamycin | 2% | Cream | 40gm | 073093 | PKR 505.03 | PKR 12.63/g | 🔒 Pharma Pro |
| Bamezole | Omeprazole | 20 mg | Tablet | 2x7's | 075001 | PKR 253.39 | PKR 18.10/tablet | 🔒 Pharma Pro |
| Bamezole | Omeprazole | 40 mg | Tablet | 14's | 075002 | PKR 439.44 | PKR 31.39/tablet | 🔒 Pharma Pro |
| Bamol | Paracetamol | 500 mg | Tablet | 20x10's | 026306 | PKR 613.77 | PKR 3.07/tablet | 🔒 Pharma Pro |
| Baprofen | Ibuprofen | 200 mg | Tablet | 50x10's | 026300 | PKR 1,160.28 | PKR 2.32/tablet | 🔒 Pharma Pro |
| Baprofen | Ibuprofen | 400 mg | Tablet | 25x10's | 026301 | PKR 858.90 | PKR 3.44/tablet | 🔒 Pharma Pro |
| Bepine | Carbamazepine | 200 mg | Tablet | 50's | 075017 | PKR 200.69 | PKR 4.01/tablet | 🔒 Pharma Pro |
| Bepram | Citalopram | 20 mg | Tablet | 14's | 075016 | PKR 716.45 | PKR 51.18/tablet | 🔒 Pharma Pro |
| Bericin | Clarithromycin | 250 mg | Tablet | 1x10's | 057490 | PKR 422.33 | PKR 42.23/tablet | 🔒 Pharma Pro |
| Bericin | Clarithromycin | 500 mg | Tablet | 1x10's | 057491 | PKR 783.07 | PKR 78.31/tablet | 🔒 Pharma Pro |
| Bisacodyl | Bisacodyl | 5 mg | Tablet | 100's | 057480 | PKR 62.70 | PKR 0.63/tablet | 🔒 Pharma Pro |
| Bstatin | Polymyxin B + Gramicidin + Lidocaine | 10000 units + 250 mcg + 50 mg per g | Cream | 10g | 073098 | PKR 60.20 | PKR 6.02/g | No comparator |
| Ciprofloxacin | Ciprofloxacin | 250 mg | Tablet | 1x10's | 057488 | PKR 228.77 | PKR 22.88/tablet | 🔒 Pharma Pro |
| Ciprofloxacin | Ciprofloxacin | 500 mg | Tablet | 1x10's | 057489 | PKR 378.35 | PKR 37.84/tablet | 🔒 Pharma Pro |
| Claridine | Loratadine | 10 mg | Tablet | 1x10's | 036184 | PKR 126.71 | PKR 12.67/tablet | 🔒 Pharma Pro |
| Cotrimoxazole | Sulfamethoxazole | 400 mg | Tablet | 20x10's | 026298 | PKR 455.63 | PKR 2.28/tablet | 🔒 Pharma Pro |
| Cotrimoxazole | Sulfamethoxazole | 400 mg | Tablet | 200's | 026298 | PKR 344.88 | PKR 1.72/tablet | 🔒 Pharma Pro |
| Cotrimoxazole DS | Sulfamethoxazole + Trimethoprim | 800 mg + 160 mg | Tablet | 100's | 026299 | PKR 344.88 | PKR 3.45/tablet | 🔒 Pharma Pro |
| Cotrimoxazole DS | Sulfamethoxazole + Trimethoprim | 800 mg + 160 mg | Tablet | 20x5's | 026299 | PKR 437.49 | PKR 4.37/tablet | 🔒 Pharma Pro |
| CTM | Clotrimazole | 500 mg | Tablet | 1x1 | 024266 | PKR 123.18 | PKR 123.18/tablet | 🔒 Pharma Pro |
| Depstal | Escitalopram | 10 mg | Tablet | 14's | 075015 | PKR 701.92 | PKR 50.14/tablet | 🔒 Pharma Pro |
| Depstal | Escitalopram | 10 mg | Tablet | 10's | 075015 | PKR 501.71 | PKR 50.17/tablet | 🔒 Pharma Pro |
| Diloxide | Metronidazole | 200 mg | Tablet | 3x10's | 075003 | PKR 79.18 | PKR 2.64/tablet | 🔒 Pharma Pro |
| Diloxide DS | Metronidazole + Diloxanide furoate | 400 mg + 500 mg | Tablet | 15's | 075004 | PKR 79.18 | PKR 5.28/tablet | 🔒 Pharma Pro |
| Enalzide | Hydrochlorothiazide | 10 mg | Tablet | 2x10's | 077678 | PKR 193.58 | PKR 9.68/tablet | 🔒 Pharma Pro |
| Flint | Metronidazole | 200 mg | Tablet | 20x10's | 036181 | PKR 292.61 | PKR 1.46/tablet | 🔒 Pharma Pro |
| Flint | Metronidazole | 400 mg | Tablet | 2x10's | 036182 | PKR 41.81 | PKR 2.09/tablet | 🔒 Pharma Pro |
| Flint | Metronidazole | 400 mg | Tablet | 10x10's | 036182 | PKR 209.00 | PKR 2.09/tablet | 🔒 Pharma Pro |
| Flint | Metronidazole | 400 mg | Tablet | 20x10's | 036182 | PKR 409.65 | PKR 2.05/tablet | 🔒 Pharma Pro |
| Fusim | Furosemide | 20 mg | Tablet | 10x10's | 077670 | PKR 204.82 | PKR 2.05/tablet | 🔒 Pharma Pro |
| Fusim | Furosemide | 40 mg | Tablet | 10x10's | 077671 | PKR 344.88 | PKR 3.45/tablet | 🔒 Pharma Pro |
| Gastrozole 40mg TabletRegistry verified | Pantoprazole sodium sesquihydrate 45.1mg eq to pantoprazole | — | — | — | 043717Official source ↗ | No indexed price | — | — |
| Iron P | Folic acid | 100 mg | Chewable tablet | 10's | 060556 | PKR 123.18 | PKR 12.32/tablet | 🔒 Pharma Pro |
| Lisozid | Lisinopril | 20 mg | Tablet | 28's | 077674 | PKR 791.88 | PKR 28.28/tablet | 🔒 Pharma Pro |
| Loxycin | Levofloxacin | 250 mg | Tablet | 10's | 057486 | PKR 439.93 | PKR 43.99/tablet | 🔒 Pharma Pro |
| Loxycin | Levofloxacin | 500 mg | Tablet | 10's | 057487 | PKR 732.04 | PKR 73.20/tablet | 🔒 Pharma Pro |
| Lumerin | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 2x8's | 075009 | PKR 563.11 | PKR 35.19/tablet | 🔒 Pharma Pro |
| Lumerin DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 075010 | PKR 464.57 | PKR 58.07/tablet | 🔒 Pharma Pro |
| Lumerin DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 10's | 075010 | PKR 545.51 | PKR 54.55/tablet | 🔒 Pharma Pro |
| Lumerin DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 2x8's | 075010 | PKR 879.86 | PKR 54.99/tablet | 🔒 Pharma Pro |
| Lysan | Losartan | 50 mg | Tablet | 2x10's | 077676 | PKR 351.93 | PKR 17.60/tablet | 🔒 Pharma Pro |
| Mefee | Moxifloxacin | 400 mg | Tablet | 5's | 063360 | PKR 439.93 | PKR 87.99/tablet | 🔒 Pharma Pro |
| Omeprazole | Omeprazole | 40 mg | Capsule | 14's | 108319 | PKR 357.52 | PKR 25.54/capsule | 🔒 Pharma Pro |
| Omeprazole | Omeprazole | 20 mg | Capsule | 14's | 108320 | PKR 205.93 | PKR 14.71/capsule | 🔒 Pharma Pro |
All 33 Batala Pharmaceuticals brands in Pakistan
- Albendazole Albendazole · 200 mg tablet
- Allotal Allopurinol · 300 mg tablet
- AML Amlodipine · 5 mg tablet
- B Zole Clotrimazole · 2% cream
- B-Dexy Doxycycline · 100 mg capsule
- B-Flucon Clindamycin · 2% cream
- Bamezole Omeprazole · 20 mg tablet, 40 mg tablet
- Bamol Paracetamol · 500 mg tablet
- Baprofen Ibuprofen · 200 mg tablet, 400 mg tablet
- Bepine Carbamazepine · 200 mg tablet
- Bepram Citalopram · 20 mg tablet
- Bericin Clarithromycin · 250 mg tablet, 500 mg tablet
- Bisacodyl Bisacodyl · 5 mg tablet
- Bstatin Polymyxin B + Gramicidin + Lidocaine · 10000 units + 250 mcg + 50 mg per g cream
- Ciprofloxacin Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Claridine Loratadine · 10 mg tablet
- Cotrimoxazole Sulfamethoxazole · 400 mg tablet
- Cotrimoxazole DS Sulfamethoxazole + Trimethoprim · 800 mg + 160 mg tablet
- CTM Clotrimazole · 500 mg tablet
- Depstal Escitalopram · 10 mg tablet
- Diloxide Metronidazole · 200 mg tablet
- Diloxide DS Metronidazole + Diloxanide furoate · 400 mg + 500 mg tablet
- Enalzide Hydrochlorothiazide · 10 mg tablet
- Flint Metronidazole · 200 mg tablet, 400 mg tablet
- Fusim Furosemide · 20 mg tablet, 40 mg tablet
- Iron P Folic acid · 100 mg tablet
- Lisozid Lisinopril · 20 mg tablet
- Loxycin Levofloxacin · 250 mg tablet, 500 mg tablet
- Lumerin Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Lumerin DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Lysan Losartan · 50 mg tablet
- Mefee Moxifloxacin · 400 mg tablet
- Omeprazole Omeprazole · 20 mg capsule, 40 mg capsule
Batala Pharmaceuticals: common questions
How many products does Batala Pharmaceuticals have in Pakistan?
Batala Pharmaceuticals has 50 registered medicine presentations in Pakistan, sold under 33 brands and covering 29 generic medicines.
What are the main brands of Batala Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Flint (Metronidazole), Lumerin DS (Artemether + Lumefantrine), Omeprazole (Omeprazole), B-Dexy (Doxycycline) and Bamezole (Omeprazole). This is not a sales ranking.
Which therapy areas does Batala Pharmaceuticals cover?
The most products are in Anti-infectives (28), Cardiovascular (6), Gastrointestinal & hepatology (6), Pain & musculoskeletal (4) and CNS & mental health (4).
Where can I see Batala Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.